Toronto, Ontario, and Edmonton, Alberta, Canada
From the Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Toronto; and the Divisions of Plastic and Reconstructive Surgery and Critical Care, Department of Surgery, University of Alberta.
Received for publication October 28, 2015; accepted April 11, 2016.
Disclosure:Dr. Tredget is a principal investigator for Scar X Therapeutics, British Canadian BioSciences Corp., and Klox Therapeutics. The remaining authors have no financial interest to declare in relation to the content of this article.
Related Video content is available for this article. The videos can be found under the “Related Videos” section of the full-text article, or, for Ovid users, using the URL citations published in the article.
Edward E. Tredget, M.D., M.Sc., 2D2.28 WMC, 8440-112 Street, University of Alberta, Edmonton, Alberta T6G 2B7, Canada, [email protected]